Pacritinib (Standard)
Product Specifications
UNSPSC Description
Pacritinib (Standard) is the analytical standard of Pacritinib. This product is intended for research and analytical applications. Pacritinib (SB1518) is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V617F mutant (IC50=19 nM). Pacritinib also inhibits FLT3 (IC50=22 nM) and its mutant FLT3D835Y (IC50=6 nM).
Target Antigen
FLT3; JAK
Type
Reference Standards
Related Pathways
Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pacritinib-standard.html
Smiles
C1(COC/C=C/COCC2=C(OCCN3CCCC3)C=CC4=C2)=CC=CC(C5=N/C(NC=C5)=N\4)=C1
Molecular Weight
472.58
References & Citations
[1]Hart S, et al. SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies. Leukemia. 2011 Nov;25(11):1751-9.|[2]Hart S, et al. Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia. Blood Cancer J. 2011 Nov;1(11):e44.|[3]William AD, et al. Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JA
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-16379R/Pacritinib-Standard-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-16379R/
CAS Number
937272-79-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7034911-01 0.02 mg
Recombinant Zymomonas mobilis Membrane protein insertase YidC (yidC)
Ask
View Details 
MBS7034911-02 0.1 mg
Recombinant Zymomonas mobilis Membrane protein insertase YidC (yidC)
Ask
View Details MBS7034911-03 5x 0.1 mg
Recombinant Zymomonas mobilis Membrane protein insertase YidC (yidC)
Ask
View Details